StreetInsider.com News Articles

Form 8-K Precipio, Inc. For: Jun 15

Mon, 15 Jun 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260615/26647166.html

Form 8-K Precipio, Inc. For: Jun 15

Mon, 15 Jun 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260615/26647166.html

Precipio seeks shareholder votes to meet quorum for annual meeting

Fri, 12 Jun 2026 13:00:37 -0400

Precipio Inc. (NASDAQ: PRPO) announced it needs additional shareholder votes to meet the required quorum for its annual shareholders meeting scheduled for June 15, 2026, at 10 a.m. Eastern Time.

The cancer diagnostics company reported that approximately 42% of shares have been voted as of the press release date. The company requires a minimum of 50% of shares to be voted to establish quorum for the meeting to proceed.

Shareholders must submit their voting instructions to brokers by 11:59 p.m. Eastern Time on June 14, 2026, for votes to be counted at the annual meeting. The company stated that votes are needed

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Fri, 12 Jun 2026 13:00:00 -0400

NEW HAVEN, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately. Votes must be received by 11:59 p.m., Eastern Time, on June 14, 2026, to be voted at the Annual Meeting.

In order to ensure that there is a quorum required for the shareholders’ meeting that is scheduled to take place tomorrow, June 15, 2026, at 10 a.m. Eastern Time.

At the time of this press release, approximately 42%

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Fri, 12 Jun 2026 13:00:00 -0400

In order to ensure that there is a quorum required for the shareholders’ meeting that is scheduled to take place tomorrow, June 15, 2026, at 10 a.m. Eastern Time.

At the time of this press release, approximately 42%

Precipio to Present at the Planet MicroCap Las Vegas

Thu, 11 Jun 2026 17:00:00 -0400

NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that it will be presenting at the Planet MicroCap Las Vegas 2026 on Wednesday, June 17, 2026, at 9:00 AM (Local Time, 12:00pm EST) at the Bellagio Resort & Hotel. Ilan Danieli, CEO and Zaki Sabet, COO of Precipio will be hosting the presentation and answering questions at the conclusion.

“We’re excited to participate in the Planet MicroCap conference and are looking forward to meeting with many of

Precipio to Present at the Planet MicroCap Las Vegas

Thu, 11 Jun 2026 17:00:00 -0400

“We’re excited to participate in the Planet MicroCap conference and are looking forward to meeting with many of

Precipio to Present at the Planet MicroCap Las Vegas

Thu, 11 Jun 2026 17:00:00 -0400

“We’re excited to participate in the Planet MicroCap conference and are looking forward to meeting with many of

Precipio to Present at the Planet MicroCap Las Vegas

Thu, 11 Jun 2026 17:00:00 -0400

“We’re excited to participate in the Planet MicroCap conference and are looking forward to meeting with many of

Form 4 Precipio, Inc. For: May 21 Filed by: SANDBERG RICHARD A

Tue, 26 May 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260526/26549625.html

Form 4 Precipio, Inc. For: May 21 Filed by: SANDBERG RICHARD A

Tue, 26 May 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260526/26549625.html

Form 4 Precipio, Inc. For: May 19 Filed by: SANDBERG RICHARD A

Thu, 21 May 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260521/26534997.html

Form 4 Precipio, Inc. For: May 19 Filed by: SANDBERG RICHARD A

Thu, 21 May 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260521/26534997.html

Form 144 Precipio, Inc. Filed by: SANDBERG RICHARD A

Tue, 19 May 2026 14:20:00 -0400

si-local-file:///var/storage/secattach/20260519/26520354.html

Form 144 Precipio, Inc. Filed by: SANDBERG RICHARD A

Tue, 19 May 2026 14:20:00 -0400

si-local-file:///var/storage/secattach/20260519/26520354.html

Precipio Announces Q1 2026 Financial Results

Thu, 14 May 2026 17:00:00 -0400

NEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces financial results for the first quarter ended March 31, 2026.

Below are some of the key financial performance metrics for the Company. Please see the Company’s Form 10-Q which was filed today for additional details.

Revenue – $6.71M (vs. $6.69M in Q4-2025; $4.93M in Q1-2025). This was comprised of $6.05M in pathology revenue (up from $5.9M in Q4) and $0.66M

Precipio Announces Q1 2026 Financial Results

Thu, 14 May 2026 17:00:00 -0400

NEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces financial results for the first quarter ended March 31, 2026.

Below are some of the key financial performance metrics for the Company. Please see the Company’s Form 10-Q which was filed today for additional details.

Revenue – $6.71M (vs. $6.69M in Q4-2025; $4.93M in Q1-2025). This was comprised of $6.05M in pathology revenue (up from $5.9M in Q4) and $0.66M

Precipio Announces Q1 2026 Financial Results

Thu, 14 May 2026 17:00:00 -0400

NEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces financial results for the first quarter ended March 31, 2026.

Below are some of the key financial performance metrics for the Company. Please see the Company’s Form 10-Q which was filed today for additional details.

Revenue – $6.71M (vs. $6.69M in Q4-2025; $4.93M in Q1-2025). This was comprised of $6.05M in pathology revenue (up from $5.9M in Q4) and $0.66M

Precipio Announces Q1 2026 Financial Results

Thu, 14 May 2026 17:00:00 -0400

NEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces financial results for the first quarter ended March 31, 2026.

Below are some of the key financial performance metrics for the Company. Please see the Company’s Form 10-Q which was filed today for additional details.

Revenue – $6.71M (vs. $6.69M in Q4-2025; $4.93M in Q1-2025). This was comprised of $6.05M in pathology revenue (up from $5.9M in Q4) and $0.66M

Form 10-Q Precipio, Inc. For: Mar 31

Thu, 14 May 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260514/26495260.html

Form 10-Q Precipio, Inc. For: Mar 31

Thu, 14 May 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260514/26495260.html

Management team’s 2025 market-based Options have vested

Wed, 13 May 2026 17:00:00 -0400

NEW HAVEN, Conn., May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that 2025 employee stock options granted to certain members of Precipio’s management team vested last week because the Company’s Common Stock price increased by more than 400% since the options were granted.

As proposed by the Company’s Compensation Committee in late 2024, rather than the standard 4-year time-based vesting period, management was offered and agreed to a market-based vesting structure whereby the options fully vest once the Company’s share price exceeds

Management team’s 2025 market-based Options have vested

Wed, 13 May 2026 17:00:00 -0400

Management team’s 2025 market-based Options have vested

Wed, 13 May 2026 17:00:00 -0400

Management team’s 2025 market-based Options have vested

Wed, 13 May 2026 17:00:00 -0400